AAPL311.74-4.49 (-1.42%) ▼|ABBV249.21+0.43 (+0.17%) ▲|ABT105.72+0.20 (+0.19%) ▲|ACN176.75-2.28 (-1.27%) ▼|ADBE257.46+0.20 (+0.08%) ▲|AMAT467.39-5.41 (-1.14%) ▼|AMD522.42+16.68 (+3.30%) ▲|AMGN390.72-2.46 (-0.62%) ▼|AMT175.63-0.10 (-0.06%) ▼|AMZN252.23-4.74 (-1.84%) ▼|AVGO364.57-3.99 (-1.08%) ▼|AXP322.83-3.28 (-1.00%) ▼|BA208.75-1.98 (-0.94%) ▼|BAC62.78+0.39 (+0.62%) ▲|BKNG172.74-7.57 (-4.20%) ▼|BLK1,079.84-15.54 (-1.42%) ▼|BMY64.62-0.07 (-0.11%) ▼|BNY163.39+0.54 (+0.33%) ▲|BRK-B509.18+3.35 (+0.66%) ▲|C138.16+1.42 (+1.03%) ▲|CAT817.45-5.04 (-0.61%) ▼|CL88.31-0.11 (-0.12%) ▼|CMCSA24.54-1.80 (-6.82%) ▼|COF212.55-1.41 (-0.66%) ▼|COP136.74+1.70 (+1.26%) ▲|COST899.91-10.27 (-1.13%) ▼|CRM247.38-1.74 (-0.70%) ▼|CSCO109.72+0.55 (+0.50%) ▲|CVS95.60-0.47 (-0.49%) ▼|CVX213.33+3.53 (+1.68%) ▲|DE674.23-6.51 (-0.96%) ▼|DHR205.10-0.13 (-0.06%) ▼|DIS104.63-0.43 (-0.41%) ▼|DUK120.02-1.22 (-1.01%) ▼|EMR151.40-0.76 (-0.50%) ▼|FDX309.89-4.24 (-1.35%) ▼|GD353.01-3.57 (-1.00%) ▼|GE325.34-9.57 (-2.86%) ▼|GEV953.97-17.35 (-1.79%) ▼|GILD145.95-0.69 (-0.47%) ▼|GM84.97-0.82 (-0.96%) ▼|GOOG329.06-6.32 (-1.88%) ▼|GOOGL331.34-7.02 (-2.07%) ▼|GS1,036.29-0.24 (-0.02%) ▼|HD310.83-2.87 (-0.91%) ▼|HON206.58-1.66 (-0.80%) ▼|IBM236.16+4.07 (+1.75%) ▲|INTC105.65+1.18 (+1.12%) ▲|INTU315.59-3.34 (-1.05%) ▼|ISRG351.85+1.69 (+0.48%) ▲|JNJ267.83-1.29 (-0.48%) ▼|JPM355.26+1.75 (+0.50%) ▲|KO87.87-0.50 (-0.56%) ▼|LIN466.03-2.35 (-0.50%) ▼|LLY1,126.41+2.50 (+0.22%) ▲|LMT525.97-10.18 (-1.90%) ▼|LOW198.81-2.00 (-0.99%) ▼|LRCX315.64-4.78 (-1.49%) ▼|MA569.75-1.15 (-0.20%) ▼|MCD255.40-0.41 (-0.16%) ▼|MDLZ61.95+0.32 (+0.52%) ▲|MDT92.48+0.09 (+0.10%) ▲|META653.30+39.82 (+6.49%) ▲|MMM164.81-2.72 (-1.62%) ▼|MO67.77-0.40 (-0.59%) ▼|MRK148.19-0.27 (-0.18%) ▼|MS216.40+0.16 (+0.07%) ▲|MSFT492.84-1.11 (-0.22%) ▼|MU1,022.62+22.36 (+2.24%) ▲|NEE82.89-0.95 (-1.13%) ▼|NFLX76.38-0.40 (-0.51%) ▼|NKE37.21-0.90 (-2.35%) ▼|NOW131.20-3.01 (-2.24%) ▼|NVDA224.25-1.48 (-0.66%) ▼|ORCL163.14+0.62 (+0.38%) ▲|PEP136.57-1.88 (-1.36%) ▼|PFE27.93+0.14 (+0.49%) ▲|PG142.94-2.64 (-1.81%) ▼|PLTR170.85+0.55 (+0.32%) ▲|PM185.24+0.51 (+0.27%) ▲|QCOM175.09+1.00 (+0.57%) ▲|RTX198.76-0.05 (-0.03%) ▼|SBUX100.83-1.19 (-1.16%) ▼|SCHW107.34+0.47 (+0.44%) ▲|SO88.21-0.78 (-0.88%) ▼|SPG206.38-3.25 (-1.55%) ▼|T25.10-0.51 (-1.97%) ▼|TMO606.16+3.14 (+0.52%) ▲|TMUS177.68-4.01 (-2.21%) ▼|TSLA368.98+0.82 (+0.22%) ▲|TXN261.45+2.53 (+0.98%) ▲|UBER71.71-1.42 (-1.94%) ▼|UNH392.19-8.65 (-2.16%) ▼|UNP284.77-3.68 (-1.28%) ▼|UPS99.34-1.15 (-1.14%) ▼|USB62.18-0.31 (-0.50%) ▼|V368.41-0.23 (-0.06%) ▼|VZ49.60-0.82 (-1.62%) ▼|WFC89.63+1.67 (+1.90%) ▲|WMT105.88-0.17 (-0.16%) ▼|XOM164.66+4.00 (+2.49%) ▲|AAPL311.74-4.49 (-1.42%) ▼|ABBV249.21+0.43 (+0.17%) ▲|ABT105.72+0.20 (+0.19%) ▲|ACN176.75-2.28 (-1.27%) ▼|ADBE257.46+0.20 (+0.08%) ▲|AMAT467.39-5.41 (-1.14%) ▼|AMD522.42+16.68 (+3.30%) ▲|AMGN390.72-2.46 (-0.62%) ▼|AMT175.63-0.10 (-0.06%) ▼|AMZN252.23-4.74 (-1.84%) ▼|AVGO364.57-3.99 (-1.08%) ▼|AXP322.83-3.28 (-1.00%) ▼|BA208.75-1.98 (-0.94%) ▼|BAC62.78+0.39 (+0.62%) ▲|BKNG172.74-7.57 (-4.20%) ▼|BLK1,079.84-15.54 (-1.42%) ▼|BMY64.62-0.07 (-0.11%) ▼|BNY163.39+0.54 (+0.33%) ▲|BRK-B509.18+3.35 (+0.66%) ▲|C138.16+1.42 (+1.03%) ▲|CAT817.45-5.04 (-0.61%) ▼|CL88.31-0.11 (-0.12%) ▼|CMCSA24.54-1.80 (-6.82%) ▼|COF212.55-1.41 (-0.66%) ▼|COP136.74+1.70 (+1.26%) ▲|COST899.91-10.27 (-1.13%) ▼|CRM247.38-1.74 (-0.70%) ▼|CSCO109.72+0.55 (+0.50%) ▲|CVS95.60-0.47 (-0.49%) ▼|CVX213.33+3.53 (+1.68%) ▲|DE674.23-6.51 (-0.96%) ▼|DHR205.10-0.13 (-0.06%) ▼|DIS104.63-0.43 (-0.41%) ▼|DUK120.02-1.22 (-1.01%) ▼|EMR151.40-0.76 (-0.50%) ▼|FDX309.89-4.24 (-1.35%) ▼|GD353.01-3.57 (-1.00%) ▼|GE325.34-9.57 (-2.86%) ▼|GEV953.97-17.35 (-1.79%) ▼|GILD145.95-0.69 (-0.47%) ▼|GM84.97-0.82 (-0.96%) ▼|GOOG329.06-6.32 (-1.88%) ▼|GOOGL331.34-7.02 (-2.07%) ▼|GS1,036.29-0.24 (-0.02%) ▼|HD310.83-2.87 (-0.91%) ▼|HON206.58-1.66 (-0.80%) ▼|IBM236.16+4.07 (+1.75%) ▲|INTC105.65+1.18 (+1.12%) ▲|INTU315.59-3.34 (-1.05%) ▼|ISRG351.85+1.69 (+0.48%) ▲|JNJ267.83-1.29 (-0.48%) ▼|JPM355.26+1.75 (+0.50%) ▲|KO87.87-0.50 (-0.56%) ▼|LIN466.03-2.35 (-0.50%) ▼|LLY1,126.41+2.50 (+0.22%) ▲|LMT525.97-10.18 (-1.90%) ▼|LOW198.81-2.00 (-0.99%) ▼|LRCX315.64-4.78 (-1.49%) ▼|MA569.75-1.15 (-0.20%) ▼|MCD255.40-0.41 (-0.16%) ▼|MDLZ61.95+0.32 (+0.52%) ▲|MDT92.48+0.09 (+0.10%) ▲|META653.30+39.82 (+6.49%) ▲|MMM164.81-2.72 (-1.62%) ▼|MO67.77-0.40 (-0.59%) ▼|MRK148.19-0.27 (-0.18%) ▼|MS216.40+0.16 (+0.07%) ▲|MSFT492.84-1.11 (-0.22%) ▼|MU1,022.62+22.36 (+2.24%) ▲|NEE82.89-0.95 (-1.13%) ▼|NFLX76.38-0.40 (-0.51%) ▼|NKE37.21-0.90 (-2.35%) ▼|NOW131.20-3.01 (-2.24%) ▼|NVDA224.25-1.48 (-0.66%) ▼|ORCL163.14+0.62 (+0.38%) ▲|PEP136.57-1.88 (-1.36%) ▼|PFE27.93+0.14 (+0.49%) ▲|PG142.94-2.64 (-1.81%) ▼|PLTR170.85+0.55 (+0.32%) ▲|PM185.24+0.51 (+0.27%) ▲|QCOM175.09+1.00 (+0.57%) ▲|RTX198.76-0.05 (-0.03%) ▼|SBUX100.83-1.19 (-1.16%) ▼|SCHW107.34+0.47 (+0.44%) ▲|SO88.21-0.78 (-0.88%) ▼|SPG206.38-3.25 (-1.55%) ▼|T25.10-0.51 (-1.97%) ▼|TMO606.16+3.14 (+0.52%) ▲|TMUS177.68-4.01 (-2.21%) ▼|TSLA368.98+0.82 (+0.22%) ▲|TXN261.45+2.53 (+0.98%) ▲|UBER71.71-1.42 (-1.94%) ▼|UNH392.19-8.65 (-2.16%) ▼|UNP284.77-3.68 (-1.28%) ▼|UPS99.34-1.15 (-1.14%) ▼|USB62.18-0.31 (-0.50%) ▼|V368.41-0.23 (-0.06%) ▼|VZ49.60-0.82 (-1.62%) ▼|WFC89.63+1.67 (+1.90%) ▲|WMT105.88-0.17 (-0.16%) ▼|XOM164.66+4.00 (+2.49%) ▲|
27.1 C
New York
Wednesday, September 9, 2026

Tag: enrollment

newssourceFORcompanyinformationcontent1releasesmarket

EISAI TO PRESENT FOUR-YEAR EFFICACY AND SAFETY DATA ON CONTINUOUS TREATMENT WITH LECANEMAB AT THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2025

Latest findings from Eisai's robust Alzheimer's disease (AD) pipeline include results from lecanemab long-term data, an immunoassay for measuring amyloid-β protofibrils in cerebrospinal fluid,...

Centene Corporation (CNC) Faces Shareholder Ire Amidst Plummeting Stock and Lawsuit Over “Inflated Guidance” – Hagens Berman

SAN FRANCISCO, July 21, 2025 (GLOBE NEWSWIRE) -- Healthcare giant Centene Corporation (NYSE: CNC), a prominent provider of government-sponsored and commercial healthcare services, finds itself embroiled in a class action lawsuit following a dramatic plunge in its stock price. The suit, Lunstrum v. Centene Corporation, No. 25-cv-05659 (S.D.N.Y.), seeks to represent investors who purchased or acquired Centene securities between December 12, 2024, and June 30, 2025, alleging violations of the Securities Exchange Act of 1934.

Academy Dissects What the Shifting Health Care and Policy Landscape Could Mean for 2026 ACA Premium Rates and Under-65 Health Insurance Markets

WASHINGTON, July 21, 2025 /PRNewswire/ -- The American Academy of Actuaries is providing a timely, nonpartisan lens from the U.S. actuarial profession to help...

Herzing University Launches Online Bachelor of Social Work Program

New BSW program aims to help students build foundational skills toward a life-changing career MILWAUKEE, July 21, 2025 /PRNewswire/ -- Herzing University an accredited, private nonprofit...

TSA PreCheck® Enrollment Available at the ItsEasy.com Offices in the Iconic NYC Locations: The MetLife Building and Rockefeller Center

ItsEasy.com and Telos Corporation announce new TSA PreCheck enrollment centers, reinforcing their commitment to making travel as easy and convenient as possible 
ItsEasy.com and Telos Corporation announce new TSA PreCheck enrollment centers, reinforcing their commitment to making travel as easy and convenient as possible

CENTENE ALERT: Bragar Eagel & Squire, P.C. Urges Investors in Centene Corporation (CNC) to Inquire About Their Rights in Class Action Lawsuit

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Centene Corporation (CNC) To Contact Him Directly To Discuss Their Options

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Centene Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CNC

NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Centene Corporation (NYSE: CNC) between December 12, 2024 and June 30, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 8, 2025.

Momentum Advisors Launches National Scholarship to Champion Future Financial Leaders

SOMERSET, N.J., July 18, 2025 (GLOBE NEWSWIRE) -- Momentum Advisors, a respected fiduciary wealth management firm known for its principled approach and dedication to transparency, proudly unveils the Momentum Advisors Future Leaders in Finance Scholarship — a national initiative designed to uplift and invest in undergraduate students aspiring to shape the future of the financial industry.

Lowe’s Foundation Investment in Solving Skilled Trades Labor Shortage Grows to $43 Million

Third cohort of community and technical colleges grant recipients will launch and expand new training programs for thousands of aspiring tradespeople MOORESVILLE, N.C., July 18,...

Best Financial Modeling Course (2025): Corporate Finance Institute Recognized as Top Financial Training Program in Report by Expert Consumers

NEW YORK, July 18, 2025 /PRNewswire/ -- The Financial Modeling & Valuation Analyst (FMVA®) certification by Corporate Finance Institute (CFI) has been named the...

Wendy Luk Launches Soul Mission Alignment Program to Guide Spiritually Minded Professionals Into Their Higher Calling

An eight-week spiritual purpose coaching program that blends quantum healing, intuitive guidance, soul activations for Lightworkers, Starseeds, and mission-driven professionals ready to align with...

NKGen Biotech Announces New Funding to Regain Compliance with Reporting Obligations and Listing Standards

Funding in the amount of $2.0M from Japanese strategic investor, in the form of common equity PIPE with warrants.

Peanut Allergy Market Set to Grow at a 16% CAGR During the Study Period (2020-2034) Owing to Current Usage of Epinephrine, Anticipated Usage of...

The evolving peanut allergy treatment market landscape features clinical trials led by DBV Technologies (Viaskin Peanut Patch), Novartis (Remibrutinib), Aravax (PVX108), ALK-Abello (Sublingual...

MetroPlusHealth Opens Community Office in Brighton Beach, Further Expanding Access to Care in Brooklyn

Insurance assistance and essential services are offered in collaboration with South Brooklyn Health Hospital and other local community partners NEW YORK, July 16, 2025...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsEnrollment

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers